On the role of abnormal DLCOin ex-smokers without airflow limitation: Symptoms, exercise capacity and hyperpolarised helium-3 MRI

Thorax

Volumn 68, Issue 8, 2013, Pages 752-759

  Kirby, Miranda ^a,b   Owrangi, Amir ^a,b   Svenningsen, Sarah ^a,b   Wheatley, Andrew ^a   Coxson, Harvey O ^c   Paterson, Nigel A M ^b   McCormack, David G ^b   Parraga, Grace ^a,b  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; HELIUM 3; RADIOISOTOPE; UNCLASSIFIED DRUG;

6 MINUTE WALK TEST; ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; EMPHYSEMA; EXERCISE; FEMALE; FUNCTION TEST; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; ISOTOPE LABELING; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL CAPACITY; PLETHYSMOGRAPHY; PRIORITY JOURNAL; QUESTIONNAIRE; RESPIRATORY AIRFLOW; SCORING SYSTEM; SMOKING; SPIROMETRY; ST GEORGES RESPIRATORY QUESTIONNAIRE; SYMPTOMATOLOGY;

EMPHYSEMA; IMAGING/CT MRI ETC;

AGED; AGED, 80 AND OVER; ANTIMETABOLITES; CARBON MONOXIDE; DIFFUSION MAGNETIC RESONANCE IMAGING; EXERCISE TOLERANCE; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HELIUM; HUMANS; MALE; MIDDLE AGED; PLETHYSMOGRAPHY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; RESPIRATORY FUNCTION TESTS; SMOKING; TOMOGRAPHY, X-RAY COMPUTED; VITAL CAPACITY;

EID: 84879903971     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-203108     Document Type: Article

References (47)

1. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532-55. (Pubitemid 47403272)
2. Hardie JA, Buist AS, Vollmer WM, et al. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002;20:1117-22. (Pubitemid 35331867)
3. Shahab L, Jarvis MJ, Britton J, et al. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax 2006;61:1043-7. (Pubitemid 44852021)
4. Wan ES, Hokanson JE, Murphy JR, et al. Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study. Am J Respir Crit Care Med 2011;184:57-63.
5. Reid J, Cockcroft D. Severe centrilobular emphysema in a patient without airflow obstruction. Chest 2002;121:307-8. (Pubitemid 34114274)
6. Chin NK, Lim TK. A 39-year-old smoker with effort dyspnea, normal spirometry results, and low diffusing capacity. Chest 1998;113:231-3. (Pubitemid 28044951)
7. Corsico A, Niniano R, Gatto E, et al. "Nonobstructive" emphysema of the lung. Respir Med Extra 7 2007;3:189-91.
8. Klein JS, Gamsu G, Webb WR, et al. High-resolution CT diagnosis of emphysema in symptomatic patients with normal chest radiographs and isolated low diffusing capacity. Radiology 1992;182:817-21.
9. Gordon C, Gudi K, Krause A, et al. Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers. Am J Respir Crit Care Med 2011;184:224-32.
10. Nakano Y, Muro S, Sakai H, et al . Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med 2000;162:1102-8.
11. Mathew L, Kirby M, Etemad-Rezai R, et al. Hyperpolarized (3)He magnetic resonance imaging: preliminary evaluation of phenotyping potential in chronic obstructive pulmonary disease. Eur J Radiol 2011;79:140-6.
12. Chen XJ, Moller HE, Chawla MS, et al. Spatially resolved measurements of hyperpolarized gas properties in the lung in vivo. Part I: diffusion coefficient. Magn Reson Med 1999;42:721-8.
13. Saam BT, Yablonskiy DA, Kodibagkar VD, et al. MR imaging of diffusion of (3)He gas in healthy and diseased lungs. Magn Reson Med 2000;44:174-9.
14. Fain SB, Panth SR, Evans MD, et al. Early emphysematous changes in asymptomatic smokers: detection with 3He MR imaging. Radiology 2006;239:875-83. (Pubitemid 43830626)
15. Swift AJ, Wild JM, Fichele S, et al. Emphysematous changes and normal variation in smokers and COPD patients using diffusion 3He MRI. Eur J Radiol 2005;54:352-8. (Pubitemid 40719725)
16. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26:948-68. (Pubitemid 41632054)
17. Irvin C. Guide to the evaluation of pulmonary function. Physiologic basis of respiratory disease. Hamilton: BC Decker Inc, 2005: 649-58.
18. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-38. (Pubitemid 41079078)
19. Jones PW, Quirk FH, Baveystock CM, et al. A self-complete measure of health status for chronic airflow limitation. The St George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145:1321-7.
20. Jones PW, Quirk FH, Baveystock CM. The St George's respiratory questionnaire. Respir Med 1991;85(Suppl B):25-31.
21. Enright PL. The six-minute walk test. Respir Care 2003;48:783-5. (Pubitemid 47377828)
22. Parraga G, Ouriadov A, Evans A, et al . Hyperpolarized 3He ventilation defects and apparent diffusion coefficients in chronic obstructive pulmonary disease: preliminary results at 3.0 Tesla. Invest Radiol 2007;42:384-91. (Pubitemid 46788737)
23. Kirby M, Heydarian M, Svenningsen S, et al. Hyperpolarized (3)He magnetic resonance functional imaging semiautomated segmentation. Acad Radiol 2012;19:141-52.
24. Kirby M, Heydarian M, Wheatley A, et al. Evaluating bronchodilator effects in chronic obstructive pulmonary disease using diffusion-weighted hyperpolarized helium-3 magnetic resonance imaging. J Appl Physiol 2012;112:651-7.
25. Evans A, McCormack D, Ouriadov A, et al. Anatomical distribution of 3He apparent diffusion coeffi cients in severe chronic obstructive pulmonary disease. J Magn Reson Imaging 2007;26:1537-47. (Pubitemid 350291282)
26. Gevenois PA, De Vuyst P, De Maertelaer V, et al. Comparison of computed density and microscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1996;154:187-92. (Pubitemid 26255788)
27. George RB, Light RW, Matthay MA, et al. Chest medicine: essentials of pulmonary and critical care medicine, 5th edn. Philadelphia: Lippincott, Williams and Wilkins, 2005.
28. Plummer AL. The carbon monoxide diffusing capacity: clinical implications, coding, and documentation. Chest 2008;134:663-7.
29. Steenhuis LH, Groen HJ, Koeter GH, et al. Diffusion capacity and haemodynamics in primary and chronic thromboembolic pulmonary hypertension. Eur Respir J 2000;16:276-81. (Pubitemid 30624946)
30. DePaso WJ, Winterbauer RH, Lusk JA, et al. Chronic dyspnea unexplained by history, physical examination, chest roentgenogram, and spirometry. Analysis of a seven-year experience. Chest 1991;100:1293-9.
31. Paciocco G, Martinez FJ, Bossone E, et al. Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension. Eur Respir J 2001;17:647-52. (Pubitemid 32492552)
32. Morrison NJ, Abboud RT, Ramadan F, et al. Comparison of single breath carbon monoxide diffusing capacity and pressure-volume curves in detecting emphysema. Am Rev Respir Dis 1989;139:1179-87. (Pubitemid 19139842)
33. West WW, Nagai A, Hodgkin JE, et al. The National Institutes of Health Intermittent Positive Pressure Breathing trial-pathology studies. III. The diagnosis of emphysema. Am Rev Respir Dis 1987;135:123-9. (Pubitemid 17010673)
34. Woods JC, Choong CK, Yablonskiy DA, et al. Hyperpolarized 3He diffusion MRI and histology in pulmonary emphysema. Magn Reson Med 2006;56:1293-300. (Pubitemid 44865311)
35. Diaz S, Casselbrant I, Piitulainen E, et al. Validity of apparent diffusion coefficient hyperpolarized 3He-MRI using MSCT and pulmonary function tests as references. Eur J Radiol 2009;71:257-63.
36. Wang C, Mugler JP, de Lange EE, et al. Healthy nonsmokers exposed regularly to secondhand smoke have evidence of lung injury detected by hyperpolarized-3 diffusion. American Journal of Respiratory and Critical Care Medicine 2010;181. doi:10.1164/ajrccm-conference.2010.181.1-MeetingAbstracts. A5438
37. Hogg JC, Wright JL, Wiggs BR, et al. Lung structure and function in cigarette smokers. Thorax 1994;49:473-8. (Pubitemid 24170400)
38. Miller RR, Muller NL, Vedal S, et al. Limitations of computed tomography in the assessment of emphysema. Am Rev Respir Dis 1989;139:980-3. (Pubitemid 19094325)
39. Muller NL, Staples CA, Miller RR, et al. "Density mask". An objective method to quantitate emphysema using computed tomography. Chest 1988;94:782-7.
40. Sorheim IC, Johannessen A, Gulsvik A, et al. Gender differences in COPD: are women more susceptible to smoking effects than men? Thorax 2010;65:480-5.
41. Foreman MG, Zhang L, Murphy J, et al. Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study. Am J Respir Crit Care Med 2011;184:414-20.
42. Camp PG, Coxson HO, Levy RD, et al. Sex differences in emphysema and airway disease in smokers. Chest 2009;136:1480-8.
43. Marin JM, Carrizo SJ, Gascon M, et al. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:1395-9. (Pubitemid 32506605)
44. Diaz S, Casselbrant I, Piitulainen E, et al. Hyperpolarized 3He apparent diffusion coefficient MRI of the lung: reproducibility and volume dependency in healthy volunteers and patients with emphysema. J Magn Reson Imaging 2008;27:763-70. (Pubitemid 351508090)
45. Fichele S, Woodhouse N, Swift AJ, et al. MRI of helium-3 gas in healthy lungs: posture related variations of alveolar size. J Magn Reson Imaging 2004;20:331-5. (Pubitemid 38970945)
46. Berry MJ, Rejeski WJ, Adair NE, et al. Exercise rehabilitation and chronic obstructive pulmonary disease stage. Am J Respir Crit Care Med 1999;160:1248-53. (Pubitemid 29487467)
47. Carter R, Nicotra B, Blevins W, et al. Altered exercise gas exchange and cardiac function in patients with mild chronic obstructive pulmonary disease. Chest 1993;103:745-50. (Pubitemid 23086167)